ClearPoint Neuro Q1 2023 Earnings Report $16.72 -0.73 (-4.18%) As of 02/21/2025 04:00 PM Eastern Earnings HistoryForecast ClearPoint Neuro EPS ResultsActual EPS-$0.23Consensus EPS -$0.18Beat/MissMissed by -$0.05One Year Ago EPSN/AClearPoint Neuro Revenue ResultsActual Revenue$5.43 millionExpected Revenue$5.21 millionBeat/MissBeat by +$220.00 thousandYoY Revenue GrowthN/AClearPoint Neuro Announcement DetailsQuarterQ1 2023Date5/11/2023TimeN/ACLPT Upcoming EarningsClearPoint Neuro will be holding an earnings conference call on Wednesday, February 26 at 4:30 PM Eastern. Interested parties can register for or listen to the call or dial in at 201-612-7415 using passcode "413671". Conference Call ResourcesSlide DeckPress ReleaseCLPT Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Slide DeckFull Screen Slide DeckPowered by ClearPoint Neuro Earnings HeadlinesClearPoint Neuro (CLPT) to Release Earnings on WednesdayFebruary 21 at 2:07 AM | americanbankingnews.comWhile institutions own 33% of ClearPoint Neuro, Inc. (NASDAQ:CLPT), individual investors are its largest shareholders with 59% ownershipFebruary 20 at 8:37 AM | finance.yahoo.comThis simple indicator removes the “technical” out of technical tradingExperts are calling it the best buy/sell indicator of 2024… A finance whiz from northern Florida has coded an indicator that isolates the precise dates to buy in and out of the stock market. According to the creator, it allows him to ride all the market highs yet sidestep the lows. And for the first time ever, he’s sharing his indicator with the public. As you’ll see in today’s free trading session, you simply buy when the candles turn green and sell when they turn red. February 22, 2025 | ProsperityPub (Ad)Solventum (NYSE:SOLV) vs. ClearPoint Neuro (NASDAQ:CLPT) Critical AnalysisFebruary 20 at 3:21 AM | americanbankingnews.comClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for the SmartFlow CannulaFebruary 13, 2025 | finanznachrichten.deStifel maintains Clearpoint Neuro stock Buy rating, $17 targetJanuary 29, 2025 | msn.comSee More ClearPoint Neuro Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email. Email Address About ClearPoint NeuroClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.View ClearPoint Neuro ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles The Trade Desk Crashes on Earnings, But Growth Catalysts PersistHims & Hers Earnings Could Be a Game Changer—What to Do NowAnalysts See Buying Opportunity in NVIDIA Before EarningsAirbnb's Earnings: Sky High Results, Grounded Guidance?Is Coinbase Stock a Buy After Earnings?CVS Health: Earnings Beat Ignites Stock RallyQualcomm’s Post-Earnings Dip: A Prime Buying Opportunity? Upcoming Earnings Workday (2/24/2025)Intuit (2/25/2025)American Tower (2/25/2025)Bank of Montreal (2/25/2025)Bank of Nova Scotia (2/25/2025)Public Storage (2/25/2025)NVIDIA (2/26/2025)Synopsys (2/26/2025)Salesforce (2/26/2025)Lowe's Companies (2/26/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
